CASSAVA SCIENCES INC's ticker is SAVA and the CUSIP is 14817C107. A total of 148 filers reported holding CASSAVA SCIENCES INC in Q1 2023. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $471,770 | -39.1% | 38,200 | 0.0% | 0.00% | – |
Q1 2024 | $775,078 | -9.9% | 38,200 | 0.0% | 0.00% | – |
Q4 2023 | $859,882 | +35.3% | 38,200 | 0.0% | 0.00% | – |
Q3 2023 | $635,648 | -32.1% | 38,200 | 0.0% | 0.00% | – |
Q2 2023 | $936,664 | +1.7% | 38,200 | 0.0% | 0.00% | – |
Q1 2023 | $921,384 | -18.3% | 38,200 | 0.0% | 0.00% | -100.0% |
Q4 2022 | $1,128,428 | -29.4% | 38,200 | 0.0% | 0.00% | 0.0% |
Q3 2022 | $1,598,000 | +48.8% | 38,200 | 0.0% | 0.00% | – |
Q2 2022 | $1,074,000 | -22.7% | 38,200 | +2.1% | 0.00% | -100.0% |
Q1 2022 | $1,389,000 | -14.8% | 37,400 | +0.3% | 0.00% | 0.0% |
Q4 2021 | $1,630,000 | -30.3% | 37,300 | -1.1% | 0.00% | 0.0% |
Q3 2021 | $2,340,000 | -39.4% | 37,700 | -16.6% | 0.00% | -50.0% |
Q2 2021 | $3,862,000 | +132.8% | 45,200 | +22.5% | 0.00% | +100.0% |
Q1 2021 | $1,659,000 | +177.9% | 36,900 | -57.8% | 0.00% | – |
Q4 2020 | $597,000 | -58.6% | 87,500 | -30.2% | 0.00% | -100.0% |
Q3 2020 | $1,443,000 | +273.8% | 125,400 | 0.0% | 0.00% | – |
Q2 2020 | $386,000 | – | 125,400 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bleichroeder LP | 1,739,540 | $7,150,000 | 1.87% |
SPHERA FUNDS MANAGEMENT LTD. | 615,000 | $2,528,000 | 0.32% |
Worth Venture Partners, LLC | 48,535 | $200,000 | 0.12% |
Ikarian Capital, LLC | 300,000 | $1,233,000 | 0.09% |
Orbimed Advisors | 250,000 | $1,530,000 | 0.03% |
Quinn Opportunity Partners LLC | 35,687 | $147,000 | 0.02% |
BOOTHBAY FUND MANAGEMENT, LLC | 38,356 | $158,000 | 0.01% |
Jefferies Group LLC | 80,000 | $329,000 | 0.00% |
ClariVest Asset Management LLC | 33,403 | $137,000 | 0.00% |
Renaissance Technologies | 653,759 | $2,687,000 | 0.00% |